Drugs in Development
All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): RB-RQ007
Therapeutic Area: Ophthalmology Product Name: Undisclosed
Highest Development Status: Preclinical Product Type: Large molecule
Partner/Sponsor/Collaborator: Capital Venture Capital Fund
Deal Size: $66.0 million Upfront Cash: Undisclosed
Deal Type: Series C Financing April 06, 2020
Details:
The funding is inted boost company's siRNA Portfolio.
Market Place
Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace
